CSI FOCUS D-HF: The future of device-based therapies and diagnostics for heart failure: The CMO view

Friday, 23 April 2021 16:00 CEST


Howard Levin, Coridea, New York, USA

Q&A moderator:
Zoar Engelman, Coridea, New York, USA


Philip Adamson, CMO, Abbott HF

William Abraham, CMO, V-Wave

Kenneth Stein, CMO, Boston Scientific CRM

Robin Germany, CMO, Respicardia

Todd Brinton, CMO, Edwards


Live panel discussion providing the attendees with a current view of the scientific and clinical needs of these companies for new or updated diagnostics and therapies. The attendees will also be able to answer questions of the panelists.




This session is supported by: